Seaport Therapeutics Inc. Common Stock

SPTX | NASDAQ

$19.60

-$1.50 (-7.11%)

At close: Oct 30, 2026, 4:00 PM ET

$19.60

$0.00 (0.00%)

After-hours: Oct 30, 2026, 7:30 PM ET

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026
Revenue	n/a	n/a
Cost of Revenue	351K	n/a
Gross Profit	-351K	n/a
Operating Income	-65.81M	-27.54M
Interest Income	3.26M	2.13M
Pretax Income	-62.59M	-24.89M
Net Income	-62.6M	-25.41M
Selling & General & Admin	40.84M	6.11M
Research & Development	24.62M	21.43M
Other Expenses	n/a	n/a
Operating Expenses	65.46M	27.54M
Interest Expense	n/a	n/a
Selling & Marketing Expenses	n/a	n/a
Cost & Expenses	65.81M	27.54M
Income Tax Expense	15K	519K
Shares Outstanding (Basic)	53.53M	53.03M
Shares Outstanding (Diluted)	53.53M	53.03M
EPS (Basic)	-1.17	-0.48
EPS (Diluted)	-1.17	-0.48
EBITDA	-65.46M	-27.19M
EBIT	-65.81M	-27.54M
Depreciation & Amortization	351K	357K